Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Hopper

Showing results (221-230 of 250) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
British Journal of Cancer|February 24, 2011
Morphological predictors of BRCA1 germline mutations in young women with breast cancerM C Southey, S J Ramus, J G Dowty, et al.
British Journal of Cancer|September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutationsG S Dite, A S Whittemore, J A Knight, et al.
Allergy|June 23, 2016
Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergensM C Matheson, J C Reece, R K Kandane-Rathnayake, et al.
British Journal of Cancer|July 17, 1999
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancerM C Southey, A A Tesoriero, C R Andersen, et al.
The British Journal of Dermatology|August 6, 2019
Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentiginesK Vuong, B K Armstrong, M Drummond, et al.
British Journal of Cancer|November 17, 2004
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsA S Whittemore, R R Balise, P D P Pharoah, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pageof 25

Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
British Journal of Cancer|February 24, 2011
Morphological predictors of BRCA1 germline mutations in young women with breast cancerM C Southey, S J Ramus, J G Dowty, et al.
British Journal of Cancer|September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutationsG S Dite, A S Whittemore, J A Knight, et al.
Allergy|June 23, 2016
Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergensM C Matheson, J C Reece, R K Kandane-Rathnayake, et al.
British Journal of Cancer|July 17, 1999
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancerM C Southey, A A Tesoriero, C R Andersen, et al.
The British Journal of Dermatology|August 6, 2019
Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentiginesK Vuong, B K Armstrong, M Drummond, et al.
British Journal of Cancer|November 17, 2004
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsA S Whittemore, R R Balise, P D P Pharoah, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pageof 25